Efficacy of Local Anesthetic and Ozone Injection in Patients With Myofascial Pain Syndrome
NCT ID: NCT05318560
Last Updated: 2022-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
72 participants
INTERVENTIONAL
2022-06-30
2022-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dry Needling Versus Ozone in Myofascial Pain Syndrome
NCT05995639
The Effectiveness of Ozone (O2-O3) Injections in the Treatment of Myofascial Pain Syndrome
NCT04885881
Effect of Lidocaine and Ozone in Injection for Myofascial Pain
NCT06768281
Myofascial Pain Syndrome and Dextrose Prolotherapy
NCT04941118
Efficacy of Dry Needling Treatment in Myofascial Pain Syndrome
NCT05066529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Age, gender, occupation, medications, duration of diagnosis, body mass index, comorbidity, functional status and pain of these patients will be questioned. Patients will be randomly divided into three groups. A total of 3 consecutive weeks of treatment were planned.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local anesthetic injection
Patients will be injected with lidocaine and given upper trapezius muscle stretching exercises. Lidocaine injection 2cc 2% will be administered to all patients using a 26 gauge, 0.45x13 mm disposable sterile needle to the affected trigger point.
Lidocaine 2% Injectable Solution
for MPS
stretching exercise
for MPS
Ozone injection
Ozone injection will be performed on patients and upper trapezius muscle stretching exercises will be given. 8 cc of oxygen/ozone gas at a concentration of 15 µg/mL will be injected into the trigger point.
Ozone
for MPS
stretching exercise
for MPS
Stretching exercise
Patients will be given a home program that includes upper trapezius muscle stretching exercises. Upper trapezius stretching exercises will be performed twice a day for at least 15 seconds, ten sets each time, for three weeks, with one hand on the patient's back and the other hand holding the side of the head and tilting it to the side until a slight tension is felt. The exercises will be explained in the text, visual and verbal forms with the exercise form.
stretching exercise
for MPS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine 2% Injectable Solution
for MPS
Ozone
for MPS
stretching exercise
for MPS
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Presence of any cervical surgery or trauma in the past year,
* History of injection for the treatment of MAS in the last 6 months,
* Cognitive disorder,
* Rheumatological disease, fibromyalgia,
* History of metabolic diseases such as hypothyroidism and diabetes mellitus
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pamukkale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hakan Alkan
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hakan Alkan, Prof.
Role: STUDY_DIRECTOR
Pamukkale University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Hakan Alkan, Prof.
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PamukkaleU-Simsek-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.